These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10834526)

  • 1. The effect of dexamethasone on growth, mineral balance and bone mineralisation in preterm infants with chronic lung disease.
    Shrivastava A; Lyon A; McIntosh N
    Eur J Pediatr; 2000 May; 159(5):380-4. PubMed ID: 10834526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone status of children aged 5-8 years, treated with dexamethasone for chronic lung disease of prematurity.
    Eelloo JA; Roberts SA; Emmerson AJ; Ward KA; Adams JE; Mughal MZ
    Arch Dis Child Fetal Neonatal Ed; 2008 May; 93(3):F222-4. PubMed ID: 17704103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal assessment of growth and bone mineral accretion in prematurely born infants treated for chronic lung disease with dexamethasone.
    Weiler HA; Paes B; Shah JK; Atkinson SA
    Early Hum Dev; 1997 Feb; 47(3):271-86. PubMed ID: 9088794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth effects of systemic versus inhaled steroids in chronic lung disease.
    Nicholl RM; Greenough A; King M; Cheeseman P; Gamsu HR
    Arch Dis Child Fetal Neonatal Ed; 2002 Jul; 87(1):F59-61. PubMed ID: 12091295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease.
    Murphy BP; Inder TE; Huppi PS; Warfield S; Zientara GP; Kikinis R; Jolesz FA; Volpe JJ
    Pediatrics; 2001 Feb; 107(2):217-21. PubMed ID: 11158449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA
    Cochrane Database Syst Rev; 2001; (2):CD001145. PubMed ID: 11405975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2014 May; (5):CD001145. PubMed ID: 24825542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prematurity, intrauterine growth status, and early dexamethasone treatment on postnatal bone mineralisation.
    Kurl S; Heinonen K; Länsimies E
    Arch Dis Child Fetal Neonatal Ed; 2000 Sep; 83(2):F109-11. PubMed ID: 10952703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. A randomized trial.
    Romagnoli C; Zecca E; Vento G; Maggio L; Papacci P; Tortorolo G
    Pharmacology; 1999 Nov; 59(5):266-74. PubMed ID: 10529659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early dexamethasone therapy in preterm infants: a follow-up study.
    Yeh TF; Lin YJ; Huang CC; Chen YJ; Lin CH; Lin HC; Hsieh WS; Lien YJ
    Pediatrics; 1998 May; 101(5):E7. PubMed ID: 9565440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2003; (1):CD001146. PubMed ID: 12535402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dexamethasone on respirator-dependent very-low-birth-weight infants is best predicted by chest X-ray.
    Schrod L; Neuhaus T; Horwitz AE; Speer CP
    Pediatr Radiol; 2001 May; 31(5):332-8. PubMed ID: 11373920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA
    Cochrane Database Syst Rev; 2000; (2):CD001145. PubMed ID: 10796251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side effects of 2 different dexamethasone courses for preterm infants at risk of chronic lung disease: a randomized trial.
    Bloomfield FH; Knight DB; Harding JE
    J Pediatr; 1998 Sep; 133(3):395-400. PubMed ID: 9738724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.
    Stark AR; Carlo WA; Tyson JE; Papile LA; Wright LL; Shankaran S; Donovan EF; Oh W; Bauer CR; Saha S; Poole WK; Stoll BJ;
    N Engl J Med; 2001 Jan; 344(2):95-101. PubMed ID: 11150359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A three year follow up of preterm infants after moderately early treatment with dexamethasone.
    Romagnoli C; Zecca E; Luciano R; Torrioli G; Tortorolo G
    Arch Dis Child Fetal Neonatal Ed; 2002 Jul; 87(1):F55-8. PubMed ID: 12091294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body composition in infants with chronic lung disease after treatment with dexamethasone.
    Bolt RJ; van Weissenbruch MM; Roos JC; Delemarre-van de Waal HA; Cranendonk A; Lafeber HN
    Acta Paediatr; 2002; 91(7):815-21. PubMed ID: 12200909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased use of postnatal corticosteroids in extremely preterm infants without increasing chronic lung disease.
    Seth R; Gray PH; Tudehope DI
    Neonatology; 2009; 95(2):172-8. PubMed ID: 18776732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Doyle LW; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2014 May; (5):CD001146. PubMed ID: 24825456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.